| Patents for C07D 495 - Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms (21,336) |
|---|
| 10/27/2004 | CN1541211A Derivatives of N-(arylsulfonyl) beta-aminoacids comprising substituted aminomethyl group, prepn. method thereof and pharmaceutical compsns. contg same |
| 10/27/2004 | CN1539836A Processes for prodn. of thienopyrimidine derivatives |
| 10/27/2004 | CN1172917C Steroid receptor modulator compounds and methods |
| 10/26/2004 | US6809206 Contacting a phenyl ester compound with a cyclic compound in the presence of a source of cyanide or fluoride to prepare acylated cyclic 1,3-dicarbonyl compounds |
| 10/26/2004 | US6809202 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof |
| 10/21/2004 | WO2004089957A1 A novel crystalline form of dorzolamide hydrochloride |
| 10/21/2004 | WO2004089878A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE α-AMINONITRILE COMPOUND |
| 10/21/2004 | WO2004089312A2 New piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 10/21/2004 | WO2004056879A3 Spirotetrathiocarbamates and spirooxothiocarbamates |
| 10/21/2004 | WO2003062241A8 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function |
| 10/21/2004 | US20040209943 e.g., N-(3-Cyano-4,5-dimethyl-thiophen-2-yl)-2,2-diphenyl-acetamide;3-Methyl-2-phenyl-pentanoic acid-(3-cyano-5,6-dihydro-4H-cyclopenta[b]thiophen-2-yl)-amide; or N-(3-Cyano-6-methanesulfonyl-4,5,6,7-tetrahydro-thieno [2,3-c]pyridin-2-yl)-2,2-diphenyl-acetamide; |
| 10/21/2004 | US20040209865 use for reducing body weight and treating urinary incontinence; Melanin-concentrating hormone (MCH); 5-(4-chloro-phenyl)-2-[5-(2-pyrrolidin-1-yl-ethoxy)-pyridin-2-yl-ethynyl]-pyridine for example |
| 10/21/2004 | US20040209864 Substituted heterocycle fused gamma-carbolines |
| 10/21/2004 | CA2517833A1 New piperidinylamino-thieno[2,3-d] pyrimidine compounds |
| 10/20/2004 | EP1468988A1 Process of preparing disubstituted 9-alkylidenefluorenes and derivatives thereof |
| 10/20/2004 | EP1468689A1 2-methyl-thieno-benzodiazepine formulation |
| 10/20/2004 | EP1467999A1 Oxothieno[3,2-b]pyridinecarboxamides as antiviral agents |
| 10/20/2004 | EP1467978A1 Pancreatic lipase inhibitor compounds, their synthesis and use |
| 10/20/2004 | EP1467975A1 Substituted alkyl uracils and the use thereof |
| 10/20/2004 | EP1467735A2 Polymorphs of clopidogrel hydrogensulfate |
| 10/20/2004 | EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones |
| 10/20/2004 | CN1538970A Thieno [2,3-d] pyrimidinediones and use in modulation of autoimmune disease |
| 10/20/2004 | CN1538955A Pyrrolidine derivatives as factor Xa inhibitors |
| 10/20/2004 | CN1171582C Oral pharmaceutical extended release dosage form |
| 10/19/2004 | US6806287 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 10/19/2004 | US6806283 Selective serotonin receptor antagonists and therapeutic applications thereof |
| 10/19/2004 | US6806274 Quinazoline derivatives |
| 10/19/2004 | US6806025 Photoresist monomers, polymers thereof and photoresist compositons containing the same |
| 10/19/2004 | CA2296901C Piperidine derivates having anxiolytic effect |
| 10/14/2004 | WO2004087673A2 Migrastatin analogs and uses thereof |
| 10/14/2004 | WO2004087672A1 Migrastatin analog compositions and uses thereof |
| 10/14/2004 | WO2004087658A1 Indolone-acetamide derivatives, processes for preparing them and their uses |
| 10/14/2004 | WO2004087165A1 Therapeutic agent for prostatic hypertrophy |
| 10/14/2004 | WO2004087056A2 BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ |
| 10/14/2004 | US20040204478 Novel benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 10/14/2004 | US20040204450 For therapy of atherosclerosis, coronary artery disease, coronary heart disease, coronary vascular disease, peripheral vascular disease, dyslipidemia, hyperbetalipoproteinemia, hypoalphalipoproteinemia, hypercholesterolemia, hypertriglyceridemia, familial-hypercholesterolemia |
| 10/14/2004 | US20040204446 Nitrogen compounds such as N-(2-Fluoro-benzyl)-N-indan-2-yl-2-(3-methyl-2-o-tolyl-piperidin-1-yl) -acetamide, administered for prophylaxis arthritis, psoriasis, cardiovascular disorders, reperfusion injury or respiratory system disorders |
| 10/14/2004 | US20040204421 Certain 1,3-disubstituted isoquinoline derivatives |
| 10/14/2004 | US20040202656 Use of binding partners for 5-HT5 receptors for the treatment of neurodegenerative and neuropsychiatric disorders |
| 10/14/2004 | CA2520568A1 Indolone-acetamide derivatives, processes for preparing them and their uses |
| 10/14/2004 | CA2520465A1 Bi-cyclic pyrimidine inhibitors of tgf.beta. |
| 10/14/2004 | CA2520377A1 Migrastatin analog compositions and uses thereof |
| 10/13/2004 | EP1466911A2 Preparation of benzothiepines having activity as inhibitors of ileal bile acid transport and taurocholate uptake |
| 10/13/2004 | EP1466906A1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 10/13/2004 | EP1465900A1 Rho-kinase inhibitors |
| 10/13/2004 | EP1465862A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors |
| 10/13/2004 | EP1392698B1 Method for the production of 6-aryl-4h-s-triazolo[3,4-c]-thieno[2,3-e]-1,4-diazepines |
| 10/13/2004 | EP1202965B1 Indole derivatives, processes for their preparation, pharmaceutical compositions containing them and their medicinal application |
| 10/13/2004 | CN1535968A Tetrahydro pyridyl or pyridyl heterocycle derivative |
| 10/13/2004 | CN1170813C N2 phenylamidine derivatives and fungicidal composition and use |
| 10/12/2004 | US6803384 Diaminopropionic acid derivatives |
| 10/07/2004 | WO2004085401A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 10/07/2004 | WO2004085382A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same |
| 10/07/2004 | WO2004065392A8 Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands |
| 10/07/2004 | WO2004048386A3 THIENO[3,2-b]PYRIDINE-6-CARBONITRILES AND THIENO[2,3-b]PYRIDINE-5-CARBONITRILES AS PROTEIN KINASE INHIBITORS |
| 10/07/2004 | WO2003068748A9 Novel pyridine- and quinoline-derivatives |
| 10/07/2004 | US20040198814 prevention , therapy of cardiovascular disorders, dyslipidemias, glucose metabolism, hypoglycemic agents; reduce fat concentration in meat; reduce cholesterol concentration in eggs |
| 10/07/2004 | US20040198805 Novel crystalline form of dorzolamide hydrochloride |
| 10/07/2004 | US20040198781 Carbonic anhydrase inhibitor |
| 10/07/2004 | US20040198740 Therapies relating to combinations of aldose reductase inhibitors and cyclooxygenase-2 |
| 10/07/2004 | US20040198724 Contacting a cell with a quinazolinones containing sulfur or its oxides in an amount sufficient to open the potassium channels for the treatment of central or peripheral nervous system disorders |
| 10/07/2004 | US20040198721 Novel crystal forms, methods for their preparation and method for preparation of olanzapine |
| 10/07/2004 | DE10311561A1 3,4-Alkylendioxythiophen-Diole, deren Herstellung und Verwendung in Kondensatoren 3,4-alkylenedioxythiophene diols, their preparation and use in capacitors |
| 10/07/2004 | CA2520405A1 1,2,4-substituted 1,2,3,4-tetrahydro-and 1,2 dihydro-quinoline and 1,2,3,4-tetrahydro-quinoxaline derivatives as cetp inhibitors for the treatment of atherosclerosis and obesity |
| 10/06/2004 | EP1464646A1 Thieno(2,3-C) Isoquinolines for use as inhibitors of Parp |
| 10/06/2004 | EP1463733A2 Mitotic kinesin inhibitors |
| 10/06/2004 | EP1463728A2 Fused cyclic modulators of nuclear hormone receptor function |
| 10/06/2004 | EP1463507A1 Thienopyrimidine compounds as protein tyrosine kinase inhibitors |
| 10/06/2004 | EP1463505A2 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer |
| 10/06/2004 | EP1165516B1 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
| 10/06/2004 | CN1534027A New substituted penta azacyclo salt kind compound and its use in treating protein ageing related disease |
| 10/06/2004 | CN1169808C 'Beta'-carboline compound |
| 10/05/2004 | US6800763 For use as semiconductor charge transport materials, in optical, electrooptical or electronic devices like for example organic field effect transistors (fet or ofet) for thin film transistor liquid crystal displays and integrated circuit |
| 10/05/2004 | US6800653 Anticancer agents |
| 10/05/2004 | US6800650 For therapy and prophylaxis of diabetes, particularly non-insulin dependent diabetes mellitus and impaired glucose tolerance. |
| 10/05/2004 | US6800619 Urea heterocycliccarbonyl-substituted aspartic or glutamic acid derivatives |
| 10/05/2004 | CA2463719A1 Nucleotide analogs with six membered rings |
| 10/05/2004 | CA2128956C Tricyclic diazepine vasopressin antagonists |
| 09/30/2004 | WO2004062568A3 Conjugate of losartan, valsartan, candesartan or eprosartan and a chelant as contrast agent |
| 09/30/2004 | US20040192942 Fluorinated pi-bridge second order nonlinear optical chromophores and electro-optic devices therefrom |
| 09/30/2004 | US20040192940 Nonlinear response; electrical communication; mixture of thiophene compound in polymer matrix |
| 09/30/2004 | US20040192930 such as 4-[5-(4-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide for treatment of arthritis |
| 09/30/2004 | US20040192757 Reacting a 2-pyrrolidinone with alpha-keto acid; cyclization, ammonolysis , catalytic hydrogenation |
| 09/29/2004 | EP1462444A1 Intermediate for biotin and process for producing the same |
| 09/29/2004 | EP1461341A1 Process for preparing a heteroaromatic compound substituted with one or more ether groups |
| 09/29/2004 | EP1287001B1 Thiophene derivatives useful as anticancer agents |
| 09/29/2004 | EP1189905B1 Substituted heterocycle fused gamma-carbolines |
| 09/29/2004 | CN1532199A Process of 2-methyl-thiophene benzodinitro heterotropilidene |
| 09/29/2004 | CN1168738C Biotin derivatives |
| 09/29/2004 | CN1168716C Optical active tetrahydrobenzindole derivatives |
| 09/28/2004 | US6797710 Cardiovascular disorders; serine protease inhibitor; administering by mouth; bioavailability |
| 09/28/2004 | CA2224125C Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride |
| 09/23/2004 | WO2004081016A1 Polymorphs and amorphous form of (s) - (+) -clopidogrel bisulfate |
| 09/23/2004 | WO2004081015A1 Amorphous clopidogrel hydrogen sulfate |
| 09/23/2004 | WO2004081010A1 Compounds having activity at 5ht2c receptor and uses thereof |
| 09/23/2004 | WO2004080990A1 C-glycoside derivatives and salts thereof |
| 09/23/2004 | WO2004080976A1 Phthalazinone derivatives |
| 09/23/2004 | WO2004080962A1 2,4,6-phenyl substituted cyclic ketoenols |
| 09/23/2004 | WO2004080410A2 Furanose-type bicyclic carbohydrates with biological activity |
| 09/23/2004 | WO2004080271A2 Method for prognosticating the progress of breast cancer and compounds useful for prevention or treatment thereof |